Reform of drug regulation--beyond an independent drug-safety board. Ray WA, Stein CM (2006) N Engl J Med 354: 194-201 Cytochrome P450 enzymes in the generation of commercial products. Guengerich FP (2002) Nat Rev Drug Discov 1: 359-66 Bringing together the academic drug discovery community. Slusher BS, Conn PJ, Frye S, Glicksman M, Arkin M (2013) Nat Rev Drug Discov 12: 811-2 Authorship and industry financial relationships: the tie that binds. Johnson DH, Horn L (2010) J Clin Oncol 28: 1281-3 Ethics in oncology: consulting for the investment industry. Berlin J, Bruinooge SS, Tannock IF (2007) J Clin Oncol 25: 444-6 Trends in antihypertensive drug advertising, 1985-1996. Wang TJ, Ausiello JC, Stafford RS (1999) Circulation 99: 2055-7 Advocating for mutually beneficial access to shelved compounds. Pulley JM, Jerome RN, Shirey-Rice JK, Zaleski NM, Naylor HM, Pruijssers AJ, Jackson JC, Bernard GR, Holroyd KJ (2018) Future Med Chem 10: 1395-1398 GPCR structure, function, drug discovery and crystallography: report from Academia-Industry International Conference (UK Royal Society) Chicheley Hall, 1-2 September 2014. Heifetz A, Schertler GF, Seifert R, Tate CG, Sexton PM, Gurevich VV, Fourmy D, Cherezov V, Marshall FH, Storer RI, Moraes I, Tikhonova IG, Tautermann CS, Hunt P, Ceska T, Hodgson S, Bodkin MJ, Singh S, Law RJ, Biggin PC (2015) Naunyn Schmiedebergs Arch Pharmacol 388: 883-903
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.